

Lyophilised · 20mg
Retatrutide 20mg
A triple-agonist research peptide (GLP-1 / GIP / glucagon), supplied lyophilised in tamper-evident packaging. Specifications are provided by our supplier.
Lyophilised
Form
20mg
Vial
Tamper-evident
Packaging
UK
Dispatch
Choose your pack
Laboratory research use only — not for human consumption.
Optional add-on
Bacteriostatic Water 10ml
A separate diluent product for reconstitution — not part of the pack you chose above.
Cart total
Nothing selected yet
£0.00
UK dispatch · Free UK shipping over £120
About the compound
A triple-agonist research peptide
Retatrutide is an investigational peptide studied for its interaction with the GLP-1, GIP and glucagon receptors. It is one of the most-studied incretin candidates in current research literature.
Each vial we supply is filled at 20mg, lyophilised, and sealed in tamper-evident packaging labelled by lot. Specifications are provided by our supplier.
- Compound
- Retatrutide
- CAS
- 2381089-83-2
- Form
- Lyophilized white powder
- Vial size
- 20mg
- Sealing
- Crimped, tamper-evident
- Specifications
- Provided by our supplier
Questions
Before you order
Is this material suitable for human use?+
No. Everything we supply is sold strictly for in-vitro laboratory research. Nothing in our catalog is a medicine, supplement, or food product, and we do not provide guidance for human or animal administration.
How is the 20mg vial supplied?+
As a sealed, lyophilised vial, labelled by lot and packed in tamper-evident packaging.
Do you ship outside Great Britain?+
We currently ship to Great Britain only. We cannot deliver to Northern Ireland, Jersey, Guernsey or the Isle of Man.
Can I order in bulk for a study?+
Yes — for larger or recurring orders, email support@properpeptides.shop with your quantity and timeline.
Research use only. This product is supplied for in-vitro laboratory research and is not a medicine, food or cosmetic. It is not for human or veterinary use. By purchasing you confirm you are 18 or over, purchasing solely for laboratory or in-vitro research, and will not administer this product to humans or animals.